Press Releases
Official announcements and milestones from Hypopara Life's advocacy journey.
2024
Yorvipath (palopegteriparatide) Receives FDA Approval for Hypoparathyroidism
A milestone moment for the hypoparathyroidism community as the first continuous PTH replacement therapy gains approval.
2026
Hypopara Life Launches Comprehensive Hypoparathyroidism Resource Website
New website offers calcium calculator, symptom tracker, Bridge Battery research tool, and community resources.
2026
Bridge Battery Research Tool Introduced for Daily Hypopara Experience Tracking
A new research tool designed to capture the real-world daily experience of living with hypoparathyroidism.
2025
Brave Butterfly Column Debuts on Hypoparathyroidism News
Bari Vapnek begins sharing her hypoparathyroidism journey through a regular column series on Hypoparathyroidism News.
2020–2024
HypoPARA Association, Inc. — Board Member
Bari Vapnek served as a board member of the HypoPARA Association, Inc., contributing to patient advocacy, community outreach, and awareness initiatives for the hypoparathyroidism community.